Logo

PerkinElmer s Predictive Diagnostics s Biomarker Amplification Filter and prOTOF 2000 MALDI-TOF

Sep 30, 2004
Premium

PerkinElmer will provide access to Predictive Diagnostics’s Biomarker Amplification Filter technology customized for PerkinElmer’s prOTOF 2000 MALDI-TOF, PerkinElmer said this week. PerkinElmer will offer PDI’s BAMF Technology services to pharmaceutical companies and research institutions, the company added. PDI’s BAMF Technology is a suite of in silico “machine-learning technologies” and informatics tools that use a “simple” blood test for the discovery of biomarker fingerprints to diagnose diseases using high-resolution mass spectrometry data, said PerkinElmer. The technology is intended for use in serum-based tests for early diagnosis of cancer and other life-threatening diseases, the company added.

 

Filed under

Diagnostics
Breaking News
The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.